Kintara Therapeutics to Present at the Planet MicroCap Showcase 2022

SAN DIEGO, April 26, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that President and CEO Robert E. Hoffman will present a corporate…

Click here to view original post